Literature DB >> 25683753

Genetic characterization of salmonid alphavirus in Norway.

M J Hjortaas1, B Bang Jensen1, T Taksdal1, A B Olsen2, A Lillehaug1, E Trettenes1, H Sindre1.   

Abstract

Pancreas disease (PD), caused by salmonid alphavirus subtype 3 (SAV3), emerged in Norwegian aquaculture in the 1980s and is now endemic along the south-western coast. In 2011, the first cases of PD caused by marine salmonid alphavirus subtype 2 (SAV2) were reported. This subtype has spread rapidly among the fish farms outside the PD-endemic zone and is responsible for disease outbreaks at an increasing numbers of sites. To describe the geographical distribution of salmonid alphavirus (SAV), and to assess the time and site of introduction of marine SAV2 to Norway, an extensive genetic characterization including more than 200 SAV-positive samples from 157 Norwegian marine production sites collected from May 2007 to December 2012 was executed. The first samples positive for marine SAV2 originated from Romsdal, in June 2010. Sequence analysis of the E2 gene revealed that all marine SAV2 included in this study were nearly identical, suggesting a single introduction into Norwegian aquaculture. Further, this study provides evidence of a separate geographical distribution of two subtypes in Norway. SAV3 is present in south-western Norway, and marine SAV2 circulates in north-western and Mid-Norway, a geographical area which since 2010 constitutes the endemic zone for marine SAV2.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  Atlantic salmon; Norway; pancreas disease; salmonid alphavirus; sequence; subtype

Mesh:

Substances:

Year:  2015        PMID: 25683753     DOI: 10.1111/jfd.12353

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  5 in total

1.  Effect of vaccines against pancreas disease in farmed Atlantic salmon.

Authors:  Magnus Vikan Røsaeg; Ragnar Thorarinsson; Arnfinn Aunsmo
Journal:  J Fish Dis       Date:  2021-08-17       Impact factor: 2.580

2.  Experimental Piscine orthoreovirus infection mediates protection against pancreas disease in Atlantic salmon (Salmo salar).

Authors:  Morten Lund; Magnus Vikan Røsæg; Aleksei Krasnov; Gerrit Timmerhaus; Ingvild Berg Nyman; Vidar Aspehaug; Espen Rimstad; Maria Krudtaa Dahle
Journal:  Vet Res       Date:  2016-10-21       Impact factor: 3.683

3.  Relationship between viral dose and outcome of infection in Atlantic salmon, Salmo salar L., post-smolts bath-challenged with salmonid alphavirus subtype 3.

Authors:  Jiraporn Jarungsriapisit; Lindsey J Moore; Stig Mæhle; Cecilie Skår; Ann Cathrine Einen; Ingrid Uglenes Fiksdal; Hugh Craig Morton; Sigurd O Stefansson; Geir Lasse Taranger; Sonal Patel
Journal:  Vet Res       Date:  2016-10-19       Impact factor: 3.683

4.  Emergence of Salmonid Alphavirus Genotype 2 in Norway-Molecular Characterization of Viral Strains Circulating in Norway and Scotland.

Authors:  Monika J Hjortaas; Elena Fringuelli; Adérito L Monjane; Aase B Mikalsen; Christine M Jonassen; Paul Savage; Hilde Sindre
Journal:  Viruses       Date:  2021-08-06       Impact factor: 5.048

5.  Response of the Salmon Heart Transcriptome to Pancreas Disease: Differences Between High- and Low-Ranking Families for Resistance.

Authors:  N A Robinson; A Krasnov; E Burgerhout; H Johnsen; H K Moghadam; B Hillestad; M L Aslam; M Baranski; S A Boison
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.